Integrated BCI Platform

About Axoft

Axoft is pioneering a next-generation neural interface platform that combines a novel, ultra-soft implantable material with high-density electrodes and AI-driven software. Founded in 2021 and based in Cambridge, Massachusetts, the company is addressing the critical limitations of current rigid and soft BCIs—namely tissue damage, signal drift, and low resolution—to enable stable, long-term recording and stimulation. Its integrated system, which includes a proprietary Brain Foundation Model, targets transformative applications in treating conditions like paralysis, depression, and movement disorders. Axoft is a private, pre-revenue company in the pre-clinical development stage, positioning itself at the convergence of advanced materials science, electronics, and artificial intelligence.

Therapeutic Areas